Study on the CD138-positive/CD38-positive stromal cells counting in identifying chronic endometritis impairing endometrial receptivity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028200

Enrollment

Unknown

Registered

2019-12-15

Start date

2019-12-30

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometritis

Interventions

failure of primary embryo implantation:Nil

successful embryo implantation:Nil

recurrent spontaneous abortion :Nil

repeated implantation failure:Nil

recurrent embryo implantation failure:Nil

Eligibility

Sex/Gender

Female

Age

22 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. aged 22-37 years; 2. BMI 18.5-23.9 kg/m2; 3. AFC >= 5, AMH >= 1.1ng/mL, bFSH <=12.0IU/mL.

Exclusion criteria

Exclusion criteria: 1. PGT cycle; 2. Uncorrected medical or surgury disease; 3. Diseases that damage implantation, eg:Submucosal myoma of the uterus, adenomyosis of the uterus, intramuscular myoma pressing the uterine cavity, endometrial polyps greater than 1cm, intrauterine adhesion.

Design outcomes

Primary

Measure	Time frame
CD38 positive endometrial stromal cells;CD138 positive endometrial stromal cells;	—

Countries

China

Contacts

Public ContactLi Yanping

Reproductive Medicine Center, Xiangya Hosipital, Central South University

lyp7798@126.com+86 13607317798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026